Affinity Asset Advisors’s Lexeo Therapeutics LXEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14.4M Buy
3,589,355
+2,108,474
+142% +$8.48M 1.97% 12
2025
Q1
$5.14M Buy
+1,480,881
New +$5.14M 0.49% 33